2019 Annual Meeting | Headache Neuromodulation Therapy

Date Wednesday 05/08/19

Time 01:00 PM - 01:45 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Live Well)

Director(s) Heidi B. Schwarz, MD, FAAN

Topic(s) Experiential Learning Area, Headache

Learning Objectives Awareness of FDA approved neuromodulation devices for headache treatment, efficacy, safety and cost.

CME Available 0.75 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic

Event Timeline
01:00 PM - 01:45 PM EDT	Speaker	Headache Neuromodulation Therapy Heidi B. Schwarz, MD, FAAN

Faculty Disclosures
Heidi B. Schwarz, MD, FAAN	Dr. Schwarz has received personal compensation for serving as an employee of University of Rochester Medical Center. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBSCO. Dr. Schwarz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepost. Dr. Schwarz has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various Law Firms.

��ɫ����